Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients.
Orphanet Journal Of Rare Diseases
Víšek, J J; Bláha, M M; Bláha, V V; Lášticová, M M; Lánska, M M; Andrýs, C C; Tebbens, J Duintjer JD; Igreja E Sá, Ivone Cristina IC; Tripská, K K; Vicen, M M; Najmanová, I I; Nachtigal, P P